Retrospective analysis of endocarditis patients to investigate the eligibility for oral antibiotic treatment in routine daily practice
Open Access
- 17 September 2020
- journal article
- research article
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 29 (2) , 105-110
Abstract
Background According to the current guidelines of the European Society of Cardiology, patients with left-sided infective endocarditis are treated with intravenous antibiotics for 4–6 weeks, leading to extensive hospital stay and high costs. Recently, the Partial Oral Treatment of Endocarditis (POET) trial suggested that partial oral treatment is effective and safe in selected patients. Here, we investigated if such patients are seen in our daily clinical practice. Methods We enrolled 119 adult patients diagnosed with left-sided infective endocarditis in a retrospective, observational study. We identified those that would be eligible for switching to partial oral antibiotic treatment as defined in the POET trial (e.g. stable clinical condition without signs of infection). Secondary objectives were to provide insight into the time until each patient was eligible for partial oral treatment, and to determine parameters of longer hospital stay and/or need for extended intravenous antibiotic treatment. Results Applying the POET selection criteria, the condition of 38 patients (32%) was stable enough to switch them to partial oral treatment, of which 18 (47.3%), 8 (21.1%), 9 (23.7%) and 3 patients (7.9%) were eligible for switching after 10, 14, 21 days or 28 days of intravenous treatment, respectively. Conclusion One-third of patients who presented with left-sided endocarditis in routine clinical practice were possible candidates for switching to partial oral treatment. This could have major implications for both the patient’s quality of life and healthcare costs. These results offer an interesting perspective for implementation of such a strategy, which should be accompanied by a prospective cost-effectiveness analysis.Keywords
This publication has 25 references indexed in Scilit:
- Partial oral treatment of endocarditisAmerican Heart Journal, 2013
- Patients Perspective on Endocarditis — An Intermezzo in LifeEuropean Journal of Cardiovascular Nursing, 2010
- Outpatient intravenous treatment for infective endocarditis: Safety, effectiveness and one-year outcomesJournal of Infection, 2009
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyArchives of internal medicine (1960), 2009
- Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective?Scandinavian Journal of Infectious Diseases, 2008
- Early Switch From Vancomycin to Oral Linezolid for Treatment of Gram-Positive Heart Valve EndocarditisThe Annals of Thoracic Surgery, 2007
- Systematic review of enhanced recovery programmes in colonic surgeryBritish Journal of Surgery, 2006
- Infective EndocarditisCirculation, 2005
- Fibroblasts Can Be Genetically Modified to Produce Excitable Cells Capable of Electrical CouplingCirculation, 2005
- TREATMENT OF RIGHT-SIDED STAPHYLOCOCCUS AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG USERS WITH CIPROFLOXACIN AND RIFAMPICINThe Lancet, 1989